Successful Treatment of Persistent Burkholderia cepacia Complex Bacteremia with Ceftazidime-Avibactam

被引:1
作者
Tamma, Pranita D. [1 ]
Fan, Yunfan [2 ]
Bergman, Yehudit [3 ]
Sick-Samuels, Anna C.
Hsu, Alice J. [4 ]
Timp, Winston [2 ]
Simner, Patricia J. [3 ]
Prokesch, Bonnie C. [5 ]
Greenberg, David E. [5 ,6 ]
机构
[1] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA
[2] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD USA
[3] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA
[4] Johns Hopkins Univ Hosp, Dept Pharm, Baltimore, MD 21287 USA
[5] Univ Texas Southwestern, Div Infect Dis, Dallas, TX 75390 USA
[6] Univ Texas Southwestern, Dept Microbiol, Dallas, TX 75390 USA
基金
美国国家卫生研究院;
关键词
Burkholderia cepacia complex; whole-genome sequencing; bacteremia; ceftazidime-avibactam; BETA-LACTAMASES; CYSTIC-FIBROSIS; SUSCEPTIBILITY; INFECTIONS; RESISTANCE; BLOOD;
D O I
10.1128/AAC.02213-17
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
We report our clinical experience treating a 2-month-old infant with congenital diaphragmatic hernia who experienced prolonged bacteremia with Burkholderia cepacia complex (Bcc) despite conventional antibiotic therapy and appropriate source control measures. The infection resolved after initiation of ceftazidime-avibactam. Whole-genome sequencing revealed that the isolate most closely resembled B. contaminans and identified the mechanism of resistance that likely contributed to clinical cure with this agent. Ceftazidime-avibactam should be considered salvage therapy for Bcc infections if other treatment options have been exhausted.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] Efficacy of ceftazidime-avibactam in the treatment of infections due to Carbapenem-resistant Enterobacteriaceae
    Basem M. Alraddadi
    Mohammed Saeedi
    Mohammed Qutub
    Abeer Alshukairi
    Ashraf Hassanien
    Ghassan Wali
    BMC Infectious Diseases, 19
  • [32] Use of Ceftazidime-Avibactam in the Treatment of Clinical Syndromes With Limited Treatment Options: A Retrospective Study
    Radha, Sneha
    Warrier, Anup R.
    Wilson, Arun
    Prakash, Shilpa
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (01)
  • [33] Clinical and Microbiological Outcomes of Ceftazidime-Avibactam Treatment in Adults with Gram-Negative Bacteremia: A Subset Analysis from the Phase 3 Clinical Trial Program
    Mazuski, John E.
    Wagenlehner, Florian
    Torres, Antoni
    Carmeli, Yehuda
    Chow, Joseph W.
    Wajsbrot, Dalia
    Stone, Gregory G.
    Irani, Paurus
    Bharucha, David
    Cheng, Karen
    Tawadrous, Margaret
    INFECTIOUS DISEASES AND THERAPY, 2021, 10 (04) : 2399 - 2414
  • [34] Clinical and Microbiological Outcomes of Ceftazidime-Avibactam Treatment in Adults with Gram-Negative Bacteremia: A Subset Analysis from the Phase 3 Clinical Trial Program
    John E. Mazuski
    Florian Wagenlehner
    Antoni Torres
    Yehuda Carmeli
    Joseph W. Chow
    Dalia Wajsbrot
    Gregory G. Stone
    Paurus Irani
    David Bharucha
    Karen Cheng
    Margaret Tawadrous
    Infectious Diseases and Therapy, 2021, 10 : 2399 - 2414
  • [35] Polyclonal outbreak of bacteremia caused by Burkholderia cepacia complex and the presumptive role of ultrasound gel
    Nannini, Esteban C.
    Ponessa, Adriana
    Muratori, Rosa
    Marchiaro, Patricia
    Ballerini, Viviana
    Flynn, Luis
    Limansky, Adriana S.
    BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, 2015, 19 (05) : 543 - 545
  • [36] Ceftazidime-Avibactam versus Meropenem for the Treatment of Complicated Intra-Abdominal Infections
    Tan, Che-Kim
    Lai, Chih-Cheng
    Chao, Chien-Ming
    ANTIBIOTICS-BASEL, 2019, 8 (04):
  • [37] Ceftazidime-Avibactam Improves Outcomes in High-Risk Neutropenic Patients with Klebsiella pneumoniae Carbapenemase-Producing Enterobacterales Bacteremia
    Herrera, Fabian
    Torres, Diego
    Laborde, Ana
    Jordan, Rosana
    Manez, Noelia
    Berruezo, Lorena
    Lambert, Sandra
    Suchowiercha, Nadia
    Costantini, Patricia
    Nenna, Andrea
    Pereyra, Maria Laura
    Benso, Jose
    Ibanez, Maria Luz Gonzalez
    Eusebio, Maria Jose
    Barcan, Laura
    Baldoni, Nadia
    Tula, Lucas
    Rossi, Ines Roccia
    Luck, Martin
    Soto, Vanesa
    Fernandez, Veronica
    Carena, Alberto angel
    MICROORGANISMS, 2024, 12 (01)
  • [38] Successful treatment of ventriculitis caused by Pseudomonas aeruginosa and carbapenem-resistant Klebsiella pneumoniae with i.v. ceftazidime-avibactam and intrathecal amikacin
    Gofman, Natalie
    To, Kim
    Whitman, Marc
    Garcia-Morales, Edgar
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2018, 75 (13) : 953 - 957
  • [39] Overcoming an Extremely Drug Resistant (XDR) Pathogen: Avibactam Restores Susceptibility to Ceftazidime for Burkholderia cepacia Complex Isolates from Cystic Fibrosis Patients
    Papp-Wallace, Krisztina M.
    Becka, Scott A.
    Zeiser, Elise T.
    Ohuchi, Nozomi
    Mojica, Maria F.
    Gatta, Julian A.
    Falleni, Monica
    Tosi, Delfina
    Borghi, Elisa
    Winkler, Marisa L.
    Wilson, Brigid M.
    LiPuma, John J.
    Nukaga, Michiyoshi
    Bonomo, Robert A.
    ACS INFECTIOUS DISEASES, 2017, 3 (07): : 502 - 511
  • [40] Ceftazidime-avibactam in the treatment of bacteremia due to carbapenem-resistant gram-negative bacteria in hematological patients: Experience in a single center
    Zhen, Sisi
    Lin, Qingsong
    Chen, Zhangjie
    Shen, Yuyan
    Chen, Xin
    Pang, Aiming
    Yang, Donglin
    Zhang, Rongli
    Ma, Qiaoling
    He, Yi
    Wei, Jialin
    Zhai, Weihua
    Jiang, Erlie
    Han, Mingzhe
    Wang, Jianxiang
    Feng, Sizhou
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2024, 30 (07) : 608 - 615